BRCA1 and fancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1

Cell Cycle

Volumn 13, Issue 23, 2014, Pages 3685-3697

  Zhang, Dong ^a,d   Zou, Jianqiu ^a   Zhang, Deli ^b   Qin, Guang ^c   Chen, Xiangming ^c   Wang, Hongmin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c Central Hospital of Taian   (China)

^d NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

BRCA1; Centrosome amplification; DNA damage response; FancJ; Interstrand cross link; PLK1

Indexed keywords

BRCA1 PROTEIN; HYDROXYUREA; MITOMYCIN; POLO LIKE KINASE 1; PROTEIN FANCJ; UNCLASSIFIED DRUG; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BRCA1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; FANCONI ANEMIA PROTEIN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

ANEUPLOIDY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA DAMAGE INDUCED CENTROSOME AMPLIFICATION; DNA REPAIR; ENZYME ACTIVATION; GENETIC PARAMETERS; HUMAN; HUMAN CELL; SOLID TUMOR; U2OS CELL LINE; CELL LINE; CENTROSOME; METABOLISM; PHYSIOLOGY;

ANIMALIA;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL LINE; CENTROSOME; DNA DAMAGE; ENZYME ACTIVATION; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 84920616984     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.964973     Document Type: Article

References (68)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID: 21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386:623-7; PMID:9121588; http://dx.doi.org/10.1038/386623a0
3. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179-204; PMID:20965415; http://dx.doi.org/10.1016/j. molcel.2010.09.019
4. Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 2012; 12:801-17; PMID:23175119; http://dx.doi.org/ 10.1038/nrc3399
5. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009; 460:278-82; PMID:19506557; http:// dx.doi.org/10.1038/nature08136
6. Silkworth WT, Nardi IK, Scholl LM, Cimini D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS One 2009; 4:e6564; PMID:19668340; http://dx.doi.org/10.1371/journal. pone.0006564
7. Chan JY. A clinical overview of centrosome amplification in human cancers. Int J Biol Sci 2011; 7:1122-44; PMID:22043171; http://dx.doi.org/10.7150/ijbs.7.1122
8. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-41; PMID:15549096; http:// dx.doi.org/10.1038/nature03099
9. Anderhub SJ, Kramer A, Maier B. Centrosome amplification in tumorigenesis. Cancer Lett 2012; 322:8-17; PMID:22342684; http://dx.doi.org/10.1016/j.canlet. 2012.02.006
10. Nigg EA, Stearns T. The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol 2011; 13:1154-60; PMID:21968988; http:// dx.doi.org/10.1038/ncb2345
11. Bornens M. The centrosome in cells and organisms. Science 2012; 335:422-6; PMID:22282802; http://dx. doi.org/10.1126/science.1209037
12. Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang H, Hurd TW, Zhou W, Cluckey A, et al. Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 2012; 150:533-48; PMID: 22863007; http://dx.doi.org/10.1016/j.cell.2012.06.028
13. Kalay E, Yigit G, Aslan Y, Brown KE, Pohl E, Bicknell LS, Kayserili H, Li Y, Tuysuz B, Nurnberg G, et al. CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat Genet 2011; 43:23-6; PMID:21131973; http://dx.doi.org/10.1038/ng.725
14. Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, et al. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet 2008; 40:232-6; PMID: 18157127; http://dx.doi.org/10.1038/ng.2007.80
15. Staples CJ, Myers KN, Beveridge RD, Patil AA, Lee AJ, Swanton C, Howell M, Boulton SJ, Collis SJ. The centriolar satellite protein Cep131 is important for genome stability. J Cell Sci 2012; 125:4770-9; PMID: 22797915; http://dx.doi.org/10.1242/jcs.104059
16. Shimada M, Komatsu K. Emerging connection between centrosome and DNA repair machinery. J Radiat Res (Tokyo) 2009; 50:295-301; http://dx.doi. org/10.1269/jrr.09039
17. Loffler H, Lukas J, Bartek J, Kramer A. Structure meets function-centrosomes, genome maintenance and the DNA damage response. Exp Cell Res 2006; 312:2633-40; PMID:16854412; http://dx.doi.org/10.1016/j. yexcr.2006.06.008
18. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR. Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 1995; 130:105-15; PMID:7790366; http://dx.doi.org/10.1083/jcb.130.1.105
19. Sibon OC, Kelkar A, Lemstra W, Theurkauf WE. DNA-replicationDNA-damage-dependent centrosome inactivation in Drosophila embryos. Nat Cell Biol 2000; 2:90-5; PMID:10655588; http://dx.doi.org/ 10.1038/35000041
20. Takada S, Kelkar A, Theurkauf WE. Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity. Cell 2003; 113:87-99; PMID:12679037; http://dx.doi.org/10.1016/S0092-8674(03)00202-2
21. Loncarek J, Hergert P, Khodjakov A. Centriole reduplication during prolonged interphase requires procentriole maturation governed by Plk1. Curr Biol 2010; 20:1277-82; PMID:20656208; http://dx.doi.org/10.1016/ j.cub.2010.05.050
22. Rai R, Phadnis A, Haralkar S, Badwe RA, Dai H, Li K, Lin SY. Differential regulation of centrosome integrity by DNA damage response proteins. Cell Cycle 2008; 7:2225-33; PMID:18635967; http://dx.doi.org/10.4161/ cc.7.14.6303
23. Bourke E, Dodson H, Merdes A, Cuffe L, Zachos G, Walker M, Gillespie D, Morrison CG. DNA damage induces Chk1-dependent centrosome amplification. EMBO Rep 2007; 8:603-9; PMID:17468739; http:// dx.doi.org/10.1038/sj.embor.7400962
24. Dodson H, Bourke E, Jeffers LJ, Vagnarelli P, Sonoda E, Takeda S, Earnshaw WC, Merdes A, Morrison C. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J 2004; 23:3864-73; PMID:15359281; http://dx.doi.org/10.1038/sj.emboj.7600393
25. Brown JA, Bourke E, Liptrot C, Dockery P, Morrison CG. MCPH1BRIT1 limits ionizing radiation-induced centrosome amplification. Oncogene 2010; 29: 5537-44; PMID:20661222; http://dx.doi.org/10.1038/ onc.2010.302
26. Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138-48; PMID:20029420; http:// dx.doi.org/10.1038/nrm2831
27. O'Donovan PJ, Livingston DM. BRCA1 and BRCA2: breastovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 2010; 31:961-7; PMID:20400477; http:// dx.doi.org/10.1093/carcin/bgq069
28. Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 1998; 95:12983-8; PMID:9789027; http://dx.doi.org/ 10.1073/pnas.95.22.12983
29. Lotti LV, Ottini L, D'Amico C, Gradini R, Cama A, Belleudi F, Frati L, Torrisi MR, Mariani-Costantini R. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 2002; 35:193-203; PMID:12353262; http://dx.doi.org/ 10.1002/gcc.10105
30. Maul GG, Jensen DE, Ishov AM, Herlyn M, Rauscher FJ, 3rd. Nuclear redistribution of BRCA1 during viral infection. Cell Growth Differ 1998; 9:743-55; PMID:9751118
31. Tarapore P, Hanashiro K, Fukasawa K. Analysis of centrosome localization of BRCA1 and its activity in suppressing centrosomal aster formation. Cell Cycle 2012; 11:2931-46; PMID:22833046; http://dx.doi.org/ 10.4161/cc.21396
32. Joukov V, Groen AC, Prokhorova T, Gerson R, White E, Rodriguez A, Walter JC, Livingston DM. The BRCA1BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell 2006; 127:539-52; PMID: 17081976; http://dx.doi.org/10.1016/j.cell.2006.08.053
33. Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, Gygi SP, Parvin JD. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004; 24:8457-66; PMID:15367667; http://dx.doi.org/10.1128/MCB.24. 19.8457-8466.2004
34. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999; 22:37-43; PMID: 10319859; http://dx.doi.org/10.1038/8743
35. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999; 3:389-95; PMID:10198641; http://dx.doi.org/10.1016/S1097-2765(00)80466-9
36. Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX, Ried T. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 2002; 21:5097-107; PMID:12140760; http://dx.doi.org/ 10.1038/sj.onc.1205636
37. Shimomura A, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Association of loss of BRCA1 expression with centrosome aberration in human breast cancer. J Cancer Res Clin Oncol 2009; 135:421-30; PMID: 18813953; http://dx.doi.org/10.1007/s00432-008-0472-5
38. Zou J, Tian F, Li J, Pickner W, Long M, Rezvani K, Wang H, Zhang D. FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1. Biology Open 2013; 2:1022-31; PMID:24167712; http://dx.doi.org/ 10.1242/bio.20135801
39. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 2013; 493:356-63; PMID:23325218; http:// dx.doi.org/10.1038/nature11863
40. Nalepa G, Enzor R, Sun Z, Marchal C, Park SJ, Yang Y, Tedeschi L, Kelich S, Hanenberg H, Clapp DW. Fanconi anemia signaling network regulates the spindle assembly checkpoint. J Clin Invest 2013; 123:3839-47; PMID:23934222; http://dx.doi.org/10.1172/JCI67364
41. Parvin JD. The BRCA1-dependent ubiquitin ligase, gamma-tubulin, and centrosomes. Environ Mol Mutagen 2009; 50:649-53; PMID:19274767; http://dx.doi. org/10.1002/em.20475
42. Schlegel BP, Starita LM, Parvin JD. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene 2003; 22:983-91; PMID:12592385; http://dx.doi.org/ 10.1038/sj.onc.1206195
43. Tian F, Sharma S, Zou J, Lin SY, Wang B, Rezvani K, Wang H, Parvin JD, Ludwig T, Canman CE, et al. BRCA1 promotes the ubiquitination of PCNA and recruitment of translesion polymerases in response to replication blockade. Proc Natl Acad Sci U S A 2013; 110:13558-63; PMID:23901102; http://dx.doi.org/ 10.1073/pnas.1306534110
44. Kais Z, Chiba N, Ishioka C, Parvin JD. Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene 2012; 31:799-804; PMID:21725363; http://dx.doi.org/ 10.1038/onc.2011.271
45. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 2001; 105:149-60; PMID: 11301010; http://dx.doi.org/10.1016/S0092-8674(01) 00304-X
46. Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 2007; 316:1194-8; PMID: 17525340; http://dx.doi.org/10.1126/science.1139476
47. Hut HM, Rembacz KP, van Waarde MA, Lemstra W, van Cappellen WA, Kampinga HH, Sibon OC. Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes. Oncogene 2005; 24:7619-23; PMID:16205648; http://dx.doi.org/10.1038/sj.onc. 1208859
48. Inanc B, Dodson H, Morrison CG. A centrosomeautonomous signal that involves centriole disengagement permits centrosome duplication in G2 phase after DNA damage. Mol Biol Cell 2010; 21:3866-77; PMID:20861312; http://dx.doi.org/10.1091/mbc. E10-02-0124
49. Liu X, Erikson RL. Activation of Cdc2cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc Natl Acad Sci U S A 2002; 99:8672-6; PMID:12077309; http://dx.doi.org/10.1073/ pnas.132269599
50. Zou J, Rezvani K, Wang H, Lee KS, Zhang D. BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress. Cell Cycle 2013; 12:2255-65; PMID:24067368; http://dx.doi.org/ 10.4161/cc.25349
51. Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, Clouin C, Taylor SS, Yaffe MB, Medema RH. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455:119-23; PMID:18615013; http://dx.doi. org/10.1038/nature07185
52. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M, Gurtler U, Garin-Chesa P, Lieb S, Quant J, et al. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 2007; 17:316-22; PMID:17291758; http:// dx.doi.org/10.1016/j.cub.2006.12.037
53. Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 2001; 276:14537-40; PMID:11278247; http://dx.doi. org/10.1074/jbc.C000881200
54. Joukov V, Chen J, Fox EA, Green JB, Livingston DM. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc Natl Acad Sci U S A 2001; 98:12078-83; PMID:11593018
55. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat Struct Biol 2001; 8:833-7; PMID:11573085; http://dx.doi.org/10.1038/nsb1001-833
56. Yu X, Chini CC, He M, Mer G, Chen J. The BRCT domain is a phospho-protein binding domain. Science 2003; 302:639-42; PMID:14576433; http://dx.doi. org/10.1126/science.1088753
57. Peng M, Litman R, Xie J, Sharma S, Brosh RM, Jr., Cantor SB. The FANCJMutLalpha interaction is required for correction of the cross-link response in FAJ cells. EMBO J 2007; 26:3238-49; PMID:17581638; http://dx.doi.org/10.1038/sj.emboj.7601754
58. Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat Struct Mol Biol 2004; 11:512-8; PMID:15133502; http://dx. doi.org/10.1038/nsmb775
59. Williams RS, Lee MS, Hau DD, Glover JN. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat Struct Mol Biol 2004; 11:519-25; PMID:15133503; http://dx.doi.org/10.1038/ nsmb776
60. Brodie KM, Henderson BR. Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase. J Biol Chem 2012; 287:7701-16; PMID:22262852; http://dx.doi.org/ 10.1074/jbc.M111.327296
61. Ransburgh DJ, Chiba N, Ishioka C, Toland AE, Parvin JD. Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. Cancer Res 2010; 70:988-95; PMID:20103620; http://dx.doi.org/10.1158/0008-5472.CAN-09-2850
62. Hiom K. FANCJ: solving problems in DNA replication. DNA Repair (Amst) 2010; 9:250-6; PMID: 20122882; http://dx.doi.org/10.1016/j.dnarep.2010.01.005
63. Cantor SB, Guillemette S. Hereditary breast cancer and the BRCA1-associated FANCJBACH1BRIP1. Future Oncol 2011; 7:253-61; PMID:21345144; http://dx. doi.org/10.2217/fon.10.191
64. Robinson HM, Black EJ, Brown R, Gillespie DA. DNA mismatch repair and Chk1-dependent centrosome amplification in response to DNA alkylation damage. Cell Cycle 2007; 6:982-92; PMID:17404511; http://dx.doi.org/10.4161/cc.6.8.4111
65. Nelms BE, Maser RS, MacKay JF, Lagally MG, Petrini JH. In situ visualization of DNA double-strand break repair in human fibroblasts. Science 1998; 280:590-2; PMID:9554850; http://dx.doi.org/10.1126/science. 280.5363.590
66. Tsou MF, Wang WJ, George KA, Uryu K, Stearns T, Jallepalli PV. Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells. Dev Cell 2009; 17:344-54; PMID:19758559; http://dx.doi.org/10.1016/j.devcel.2009.07.015
67. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434:864-70; PMID:15829956; http://dx.doi.org/ 10.1038/nature03482
68. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr., Kastrinakis NG, Levy B, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907-13; PMID:15829965; http://dx.doi.org/10.1038/ nature03485